Health Trials

About this trial

The purpose of this study is to develop an implementation protocol and test the feasibility and acceptability of a first trimester screening protocol for the early detection of gestational diabetes mellitus (GDM).

Eligibility criteria

Qualifiers

1) age greater than or equal to 18 years old,

2) singleton gestation less than or equal to 12 weeks at initial obstetric visit,

3) receiving prenatal care at UMMHC and plans to deliver at UMMHC,

4) able and willing to provide informed consent,

Disqualifiers

1) known diagnosis of pre-existing pregestational diabetes,

2) plan to receive prenatal care or deliver outside of UMMHC,

3) inability to complete oral glucose tolerance test (e.g. gastric bypass surgery history, gastric dumping syndrome history, vomiting of oral glucose tolerance test), or

4) systemic steroid use.

Trial design

Treatments tested in this trial

  • Enhanced First Trimester GDM Screening
  • Routine Gestational Diabetes Screening

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

1
University of Massachusetts Memorial Medical Center01605, WorcesterMassachusetts, United States

Sponsors and collaborators

University of Massachusetts, Worcester

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Source ClinicalTrials.gov